News Pfizer looks to M&A after results disappointment Pfizer is looking to deals to keep investors onside after a disappointing set of Q4 results.
News BMS suffers further setback in lung cancer No fast approval for immunotherapy combo in first line use.
News Pharma braces as Trump begins dismantling Obamacare Trump focused on reforming or repealing Obamacare
News AZ looks for advantage over Merck in lung cancer trial AZ rejigs endpoints in key trial of durvalumab
News Trump 'already understands' need to incentivise R&D, says Me... Frazier takes swipe at price-hiking generics firms.
News Isomorphic adds MSD to partner roster, and other deals It's been a busy dealmaking week, with Isomorphic Labs, fresh from a $5 billion financing, adding MSD to its list of research alliances.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.